Effect of Aficamten on Structure and Function in Patients with Obstructive Hypertrophic Cardiomyopathy: The FOREST-HCM CMR Sub-study

• Ahmad Masri, MD,
• Rhanderson Cardoso, MD,
• Theodore Abraham, MD,
• Lubna Choudhury, MD,
• Florian Rader, MD,
• Sara Saberi, MD,
• Albree Tower-Rader, MD,
• Andrew Wang, MD,
• Stephen Heitner, MD,
• Stuart Kupfer, MD,
• Fady Malik, MD, PhD,
• Chiara Melloni, MD,
• Jenny Wei, PhD,
• Amy Wohltman,
• Raymond Kwong, MD

Affiliations

Ahmad Masri, MD

Oregon Health and Science University,Portland, OR, USA

Rhanderson Cardoso, MD

Brigham and Women's Hospital

Theodore Abraham, MD

University of California San Francisco

Lubna Choudhury, MD

Northwestern University Feinberg School of Medicine

Florian Rader, MD

Cedars-Sinai Medical Center

Sara Saberi, MD

University of Michigan

Albree Tower-Rader, MD

Massachusetts General Hospital

Andrew Wang, MD

Duke University Hospital

Stephen Heitner, MD

Cytokinetics,

Stuart Kupfer, MD

Cytokinetics, Incorporated

Fady Malik, MD, PhD

Cytokinetics, Incorporated

Chiara Melloni, MD

Cytokinetics, Incorporated

Jenny Wei, PhD

Cytokinetics, Incorporated

Amy Wohltman

Cytokinetics, Incorporated

Raymond Kwong, MD

Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA